The stock opened at Rs 5952.05 and touched an intraday high and low of Rs 6098.4 and Rs 5952.05, respectively, in the session so far. The stock of Divi’s Laboratories Ltd. quoted a 52-week high of Rs 6098.4 and a 52-week low of Rs 3300.0.
As per BSE, the total market cap of the Divi’s Laboratories Ltd. stood at Rs 160700.08 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 2197.0 crore for the quarter ended 30-Jun-2024, down 7.77 per cent from previous quarter’s Rs 2382.0 crore and down 18.18 per cent from the year-ago quarter’s Rs 1859.0 crore.
The net profit for latest quarter stood at Rs 430.0 crore, up 20.79 per cent from the same quarter a year ago.
Shareholding pattern
As of 30-Jun-2024, DIIs held 13.1 per cent stake in the firm, while foreign institutional investors held 16.16 per cent and the promoters 51.9 per cent.
Valuation ratio
According to BSE data, the stock traded at a P/E multiple of 96.0 and a price-to-book ratio of 6.71. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Divi’s Laboratories Ltd. belongs to the Pharma – Indian industry.